Boston Scientific Faces Securities Fraud Lawsuit Over Overstated EP Growth Claims
Boston Scientific faces class action lawsuit alleging material misstatements about electrophysiology growth. Stock fell 17.6% after disclosing slower market growth and competitive pressures.
BSXsecurities fraudclass action lawsuit
